Ann Ehrenhofer-Murray is a professor of molecular cell biology at Humboldt-Universität zu Berlin. Ann studies the mechanisms of gene regulation by chromatin and RNA modifications. She initiated her studies on epigenetic gene silencing and histone acetylation as a postdoc at the University of California, Berkeley and expanded the work as an independent group leader at the Max-Planck-Institute for Molecular Genetics in Berlin. After professorships in genetics at the universities of Giessen and Duisburg-Essen, she returned to Berlin in 2013. Next to investigating the regulation of heterochromatin and centromeres through histone modifications, she more recently is studying the cross-talk of (t)RNA modifications and how they modulate protein translation.
M. A. Faghihi, M.D., Ph.D., is an Assistant Professor at The Department of Psychiatry & Behavioral Sciences at the University of Miami, Miller School of Medicine. Dr. Faghihi will also serve as a member of the Center for Therapeutic Innovation at the John P. Hussman Institute for Human Genomics. He received his medical doctorate (M.D.) degree from Shiraz University of Medical Sciences, Iran in 1994. He received his Ph.D. degree in Biomedical Sciences at the Karolinska Institute, Stockholm, Sweden in 2009. He served as a Senior Staff Scientist at the Department of Neuroscience at the Scripps Research Institute, Florida, before joining University of Miami. Dr. Faghihi is an expert in the field of RNA genetics, interested in non-coding RNA, particularly natural antisense transcripts and their involvement in neurological disorders such as Alzheimer's disease, Parkinson's disease, Multiple Sclerosis and Fragile X Syndrome.
Professor Stunnenberg is the Research Director of RIMLS/Faculty of Science, and coordinator of the EU FP7 High Impact Project BLUEPRINT (the BLUEPRINT of Haematopoietic Epigenomes) that runs from 2011-2016 (www.blueprint-epigenome.eu) and currently he is Chair of the International Scientific Steering Committee of the International Human Epigenome Consortium (IHEC).
Head of the genetic diagnostic lab National Institute for Genetic Engineering and Biotechnology. PhD from Gothenburg University. Winner of ISSCO price 2014 as best biology researcher. In slamic counties. Winner of best Researcher in medical biotechnolgy in 2015 in Iran. More than 200 publications and 17 books.
Philippe Froguel passed his Medical Degree in 1986 and he obtained a PhD in 1991 from Paris University. He is currently Professor of Genomic Medicine and head of the department genomics of common disease at the Hammersmith hospital, Imperial College London, UK. He is also Professor of Endocrinology at Lille University hospital, France, director of the CNRS/Lille University/Pasteur Institute research group "Integrated Genomics and Modelling of metabolic diseases", Director of the French laboratory of excellence on diabetes research EGID and of the equipment of excellence LIGAN-personalized medicine. PF's scientific carrier is focused on the genetics of diabetes and obesity. He is author of >630 Pubmed indexed publications and his H-index is 137. He is among the 400 most cited researchers in medical research (> 80,000). PF has identified in 1992 the first diabetes gene (glucokinase) and has published in 2007 the first Genome Wide Association Study in T2D.
Lucia Altucci is Associate Professor of General Pathology at University of Naples 2, where she is teaches the causal mechanisms of diseases with a focus on tumorigenesis to medical students, technicians and biotechnologists.Since 2014 she is collaborating with AVA and ANVUR taking part to the evaluating committee of Research centers, Universities and quality of researchers. She is Editor of the IJBCB (Elsevier) and of J Clinical Epigenetics (Biomed Central). She is part of many International committees for the evaluation of research in EU and outside.Lucia won the Presidential gold medal for her studies on Epigenetics & Cancer in 2010 and the price for cancer research given from the prestigious ‘Accademia dei Lincei’ in 2005.Her research focuses on innovative therapeutic strategies against cancer, (epi)drug discovery and development, identification of pathogenesis of diseases with a focus on cancer (epi)genome alterations.She is one of the founding members of the companies Mesogenics and Epi-C.v.
Dr Ghader Mirzaghaderi was born in 1974 in Bokan, Iran. He obtained his BSc degree (1998) in the field of Agronomy and Plant Breeding from Urmia University, his M.Sc. degree (2001) in Genetics and Plant Breeding from Tarbiat Modares University, and his Ph.D. degree (2008) in Plant Breeding from Tarbiat Modares University. Dr Mirzaghaderi joined University of Kurdistan, Sanandaj, as academic staff in 2009 and am now serve as an associate professor in Agronomy and Plant Breeding Department, Faculty of Agriculture. His research interest areas are polyploidy, meiosis and wheat-alien interspecific hybridization.
Priv.Doz. Dr. E. Korsching is PI of the Cancer & Complex Systems Research Group at the Institute of Bioinformatics of the University Hospital of Muenster. The studies in chemistry and biochemistry were brought to perfection in a PhD thesis on extra cellular matrix research. The present work focus has evolved from wet lab based research in cell and molecular biology (in a clinical setting) towards theoretical methods in biology. The foundations of the present work and the focus on clinical questions was established during the long standing research work in the pathology. The commitment to interdisciplinarity in research resulted in an ever growing research effort in theoretical biology, stimulated by the wealth of already existing mathematical and physical concepts. These concepts has been a source of inspiration in concrete research efforts in the field of breast and bone cancers. The present research program is centered around the biological reaction networks and how they form this robust and adaptive multi-cellular system. Beside these basic research efforts , which rely on simulation studies and analysis of array/sequence data sets, we apply those mechanistic insights to understand cancer formation and progression. Some further clinical projects focus on the definition of biological marker panels and quality standard.
Iran has made considerable advances in science and technology through education and training, in almost all aspects of genetics during the past two decades. For this we are proud to announce the upcoming genetics congress to be held in Tehran, Iran in 2018.
The Third International and 15th National Genetics Congress will be held from 13th to 15th May, 2018 in Tehran, Iran. The congress is hosted by the Iranian Genetics Society.
Secretariat of the Genetics Congress , Room No. 5601, 5th floor, Faculty of Life Sciences, Tarbiate Modares University, Tehran, Iran.
Congress Number: 82884745
Congress Fax: 89787971
دانشگاه تربیت مدرس- دانشکده علوم زیستی - ط 5 - اتاق 5601 دبیرخانه کنگره ژنتیک ایران